| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/22/2004 | US20040142399 Recombinant FlaA as a diagnostic reagent |
| 07/22/2004 | US20040142398 Immunoassay and method of use |
| 07/22/2004 | US20040142396 Methods and compositions for diagnosing carcinomas |
| 07/22/2004 | US20040142395 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142392 Method for determining analyte molecules in a sample |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142384 Magnetic separator |
| 07/22/2004 | US20040142383 Using proteolytic digestion to generate cleavage peptide profile and using pattern to classify source of biological material |
| 07/22/2004 | US20040142381 Somatomedin comprising tyrosine kinase domain for use in identifying modulators for treatment of cancer; drug design |
| 07/22/2004 | US20040142380 Bipolymer conjugate comprising phycoerythrine for use as diagnostic signal in flow cytometry, immunoassays and fluorescent light analysis |
| 07/22/2004 | US20040142379 using proteomica and combinatorial chemistry for drug screening/design/targets; libraries; solid phase synthesis |
| 07/22/2004 | US20040142377 dyslipidemia, atherosclerosis, coronary heart disease, stroke, insulin resistance and type 2 diabetes |
| 07/22/2004 | US20040142370 Molded low volume waveguided optical format |
| 07/22/2004 | US20040142369 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 07/22/2004 | US20040142368 Method of identifying therapeutic agents |
| 07/22/2004 | US20040142365 includes contacting at least a portion of a substrate with a reducing agent such as a hydride which substantially eliminates autofluorescence; microarrays; solid phase synthesis |
| 07/22/2004 | US20040142362 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 07/22/2004 | US20040142361 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/22/2004 | US20040142359 Methods and compositions for treating neurological disorders |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142351 Associative analysis of gene expression array data |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142347 Mitochondrial DNA autoscoring system |
| 07/22/2004 | US20040142345 Methods of screening test compounds using GADD34L, an eIF2alpha-specific phosphatase subunit |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142341 comprises porous particles with an inner surface formed within the pores and surrounded by a lipid layer spanning the openings of the pores at the external surface |
| 07/22/2004 | US20040142340 comprising an array which has immobilised oligonucleotides represented on a surface support, wherein the oligonucleotides represented have a reactive-OH group at their free 3' end, and a means of extending said 3'-OH group; solid phase synthesis |
| 07/22/2004 | US20040142338 solid phase synthesis; detection molecules can be coated with very high density for production of a compact array |
| 07/22/2004 | US20040142335 Method for determining skin stress or skin ageing in vitro |
| 07/22/2004 | US20040142332 Desaturase antigen of mycobacterium tuberculosis |
| 07/22/2004 | US20040142321 HCV assay |
| 07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
| 07/22/2004 | US20040142319 provide a hish speed/user-friendly alternative to haemagglutination-inhibition, fluorescent antibody and enzyme immunoassay, and reverse transcriptase polymerase chain reaction (RT-PCR); solid phase synthesis |
| 07/22/2004 | US20040142318 Hematology reagent and methods |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142316 Analytical test approach for blood |
| 07/22/2004 | US20040142164 Fine particle film and producing method of the same |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141985 Biossay for measuring the release of interferons from lymphocytes; inoculation against infection by mycobacterium by administering CD8 epitopes capable of inhibiting the binding of the epitopes to lymphocyte receptors |
| 07/22/2004 | US20040141983 Compositions against cancer antigen LIV-1 and uses thereof |
| 07/22/2004 | US20040141981 administering biological conjugates comprising chlorotoxin sensitive cytoplasmic proteins, used for the screening and prophylaxis of cancer |
| 07/22/2004 | US20040141979 isolation and production of cancerous disease modifying antibodies (CDMAB) and to the use of these CDMAB in therapeutic and diagnostic processes; anticancer agents |
| 07/22/2004 | US20040141977 the ATRX gene and/or its polypeptide product are anti-apoptopic, and provide a positive viability signal to the apoptotic pathway; methods for treating, diagnosing, prognosing apoptosis related diseases |
| 07/22/2004 | US20040141974 use of the protein BCMP 7, compositions comprising the protein, including vaccines, and antibodies that are immunospecific for the protein, in the diagnosis, prophylaxis and treatment of cancer |
| 07/22/2004 | US20040141972 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141971 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/22/2004 | US20040141970 recombinant production of novel DNA and novel polypeptides the presence of which is associated with inflammatory diseases (inflammation associated antigens) and/or cancer; diagnosis and treatment of conditions characterized by such antigens |
| 07/22/2004 | US20040141969 Antibody binding to platelet devived growth factor; antiproliferative agents |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141946 Methods of treating neurological conditions with hematopoietic growth factors |
| 07/22/2004 | US20040141919 Providing an effective amount of at least one halitosis associated compound in a reservoir; allowing subject to smell halitosis associated compound to detect an apparent odor of halitosis associated compound |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141915 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141914 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141913 Cancerous disease modifying antibodies |
| 07/22/2004 | US20040141888 Instrument and method for blood separation, and preparing method, quantifying method and preserving container for biological sample |
| 07/22/2004 | US20040141881 Test element analysis system |
| 07/22/2004 | US20040141880 Holder of a microarray device designed for an automatic pipetting system for automatically dispensing liquids to communicate with the microarray device; reliability |
| 07/22/2004 | US20040141188 Apparatus and method for precision testing of fiber length using electrostatic collection and control of fibers |
| 07/22/2004 | US20040141171 Ethyl alcohol sensor and method of use |
| 07/22/2004 | US20040141036 Process and apparatus for weatherability test of image |
| 07/22/2004 | US20040140427 Patch-clamping and its use in analysing subcellular features |
| 07/22/2004 | US20040140211 Modular interface and coupling system and method |
| 07/22/2004 | US20040140209 Biosensor |
| 07/22/2004 | US20040140020 Nondestructive evaluating method for aged deterioration in austenitic stainless steel |
| 07/22/2004 | US20040139888 Containing nanofillers providing superior performance; refractive index, transparency reflection, resistivity, permittivity, permeability, coercivity, magnetic hysteresis, breakdown voltage; increased surface area, constrained domain sizes |
| 07/22/2004 | US20040139791 Non-intrusive multiphase flow meter |
| 07/22/2004 | US20040139764 Method for evaluating the quality of abrasive grains, polishing method and abrasive for polishing glass |
| 07/22/2004 | DE202004005694U1 Apparatus for testing a liquid, and especially for the detection of microorganisms in water has suction connections at a frame with an adaptor for a filter holder with a membrane |
| 07/22/2004 | DE202004005279U1 Apparatus to mark tissue, and detect the difference between normal/tumor tissue, has a light bundle unit with bundles of optic fiber to carry illuminating light forward and reflected light back to the detection unit |
| 07/22/2004 | DE19955582B4 Gegenstand mit einer ungeladenen, funktionalisierten Oberfläche umfassend ein Hydrogel, Verfahren zur Herstellung und Verwendung des Gegenstandes sowie Verbindungen zur Herstellung der Oberfläche Article having an uncharged, functionalized surface which comprises a hydrogel, methods of making and use of the article as well as compounds for the preparation of the surface |
| 07/22/2004 | DE19751363B4 Verfahren und Vorrichtung zum Nachweis von Substanzemissionen Method and device for the detection of emissions substance |
| 07/22/2004 | DE10310387B3 Measurement sensor determining oxygen activity and other elements in molten metal or slag, includes solid electrolyte tube coated with calcium zirconate and a fluoride |
| 07/22/2004 | DE10300861A1 Verwendung von an FABP4 bindenden Substanzen zur Diagnose und Behandlung des Harnblasenkarzinoms Use of at FABP4 binding substances in the diagnosis and treatment of bladder cancer |
| 07/22/2004 | DE10258051A1 Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge Use of binding to HAS substances for diagnosis and treatment of squamous cell carcinoma of the lung |
| 07/22/2004 | DE10257604A1 Kapazitiver Nachweis von gebundenen Molekülen Capacitive detection of bound molecules |
| 07/22/2004 | CA2772050A1 Assay cartridges and methods of using the same |
| 07/22/2004 | CA2522750A1 Immobilisation of dna-labelled lipid vesicles on dna arrays |
| 07/22/2004 | CA2513137A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2512798A1 Fluorescence based t-type channel assay |
| 07/22/2004 | CA2512513A1 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 07/22/2004 | CA2512512A1 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | CA2512002A1 Method of selecting novel immunosuppressant |
| 07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | CA2511873A1 Modulation of protein functionalities |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | CA2511647A1 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement |
| 07/22/2004 | CA2511513A1 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | CA2511389A1 Assay cartridges and methods of using the same |
| 07/22/2004 | CA2511316A1 Bindingzyme arrays and high-throughput proteomic methods |
| 07/22/2004 | CA2508829A1 Glycopeptide identification and analysis |
| 07/22/2004 | CA2508285A1 Self-calibrated flow-through assay devices |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |